STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

AZN ASTRAZENECA PUBLIC LIMITED COMPANY StockScouter® Report

4

StockScouter® Score

ASTRAZENECA PUBLIC LIMITED COMPANY, a large cap growth company in the healthcare sector, is expected to perform in line with the market over the next six months with less than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • Earnings growth in the past year has accelerated moderately compared to earnings growth in the past three years. Positive
  • Short-term relative price momentum exhibits meaningful strength. Postive

 

Concerns

  • The enterprise value-to-sales ratio is higher than the average for comparably-sized companies in the StockScouter universe. Negative
  • One or more analysts has modestly decreased quarterly earnings estimates for AZN. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that large cap stocks will be out of favor, growth stocks will be out of favor, and healthcare stocks will be out of favor.

Expected Risk/Return

Progress: 20% done.
Progress: 60% done.
Low
High

Core Model Grades

C
C
D
C

Previous Ratings

5
6
5